Ehong Gu - Jan 2, 2024 Form 4 Insider Report for LianBio (LIAN)

Signature
/s/ Brianne Jahn, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
Jan 2, 2024
Transactions value $
-$13,237
Form type
4
Date filed
4/11/2024, 04:10 PM
Previous filing
Dec 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIAN Ordinary Shares Sale -$7.51K -1.73K -2.21% $4.34 76.8K Jan 2, 2024 Direct F1
transaction LIAN Ordinary Shares Disposed to Issuer -$5.72K -17.9K -100% $0.32* 0 Apr 9, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the sale of shares to cover personal income tax obligations upon vesting of restricted share units ('RSUs') as required pursuant to the terms of Ms. Gu's RSU award agreement. 41,078 RSUs were granted to Ms. Gu under the LianBio 2021 Equity Incentive Plan (the 'Plan') on December 31, 2021, 25% of which vested on each of December 31, 2022 and 2023 with the remainder to vest in 25% annual installments and to be fully vested on December 31, 2025, subject to Ms. Gu's providing continuous service to the Issuer on each such date. On March 22, 2024, the board of directors of the Issuer resolved to terminate the Plan and any unvested RSUs granted thereunder in accordance with the terms of the Plan, effective as of March 24, 2024. In accordance with this determination, 58,873 unvested RSUs previously reported as beneficially owned by Ms. Gu were cancelled. Ms. Gu received no value in exchange for the cancellation of the unvested RSUs.